title: Integrative methods for studying cardiac energetics.
abstract: The more recent studies of human pathologies have essentially revealed the complexity of the interactions involved at the different levels of integration in organ physiology. Integrated organ thus reveals functional properties not predictable by underlying molecular events. It is therefore obvious that current fine molecular analyses of pathologies should be fruitfully combined with integrative approaches of whole organ function. It follows an important issue in the comprehension of the link between molecular events in pathologies, and whole organ function/dysfunction is the development of new experimental strategies aimed at the study of the integrated organ physiology. Cardiovascular diseases are a good example as heart submitted to ischemic conditions has to cope both with a decreased supply of nutrients and oxygen, and the necessary increased activity required to sustain whole body-including the heart itself-oxygenation.By combining the principles of control analysis with noninvasive (31)P NMR measurement of the energetic intermediates and simultaneous measurement of heart contractile activity, we developed MoCA (for Modular Control and Regulation Analysis), an integrative approach designed to study in situ control and regulation of cardiac energetics during contraction in intact beating perfused isolated heart (Diolez et al., Am J Physiol Regul Integr Comp Physiol 293(1):R13-R19, 2007). Because it gives real access to integrated organ function, MoCA brings out a new type of information-the "elasticities," referring to internal responses to metabolic changes-that may be a key to the understanding of the processes involved in pathologies. MoCA can potentially be used not only to detect the origin of the defects associated with the pathology, but also to provide the quantitative description of the routes by which these defects-or also drugs-modulate global heart function, therefore opening therapeutic perspectives. This review presents selected examples of the applications to isolated intact beating heart and a wider application to cardiac energetics under clinical conditions with the direct study of heart pathologies.
authors: INSERM U1045, Centre de Recherche Cardio-Thoracique, Université Bordeaux, Segalen, Bordeaux, France, philippe.diolez@u-bordeaux.fr.
authors: Philippe
authors: P
authors: Diolez
authors: Véronique
authors: V
authors: Deschodt-Arsac
authors: Guillaume
authors: G
authors: Calmettes
authors: Gilles
authors: G
authors: Gouspillou
authors: Laurent
authors: L
authors: Arsac
authors: Pierre
authors: P
authors: Dos Santos
authors: Pierre
authors: P
authors: Jais
authors: Michel
authors: M
authors: Haissaguerre
mesh_terms: D002316:Cardiotonic Agents / Q000494:pharmacology; D004548:Elasticity; D004734:Energy Metabolism; D006321:Heart / Q000187:drug effects / Q000502:physiology; D006706:Homeostasis / Q000187:drug effects; D006801:Humans; D006835:Hydrazones / Q000494:pharmacology; D055432:Metabolomics / Q000379:methods*; D008929:Mitochondria, Heart / Q000187:drug effects / Q000378:metabolism*; D009206:Myocardium / Q000378:metabolism*; D032383:Myocytes, Cardiac / Q000187:drug effects / Q000378:metabolism*; D019906:Nuclear Magnetic Resonance, Biomolecular / Q000379:methods; D010101:Oxygen Consumption; D011724:Pyridazines / Q000494:pharmacology; D000077464:Simendan; D049490:Systems Biology / Q000379:methods
chemical_list: D002316:Cardiotonic Agents; D006835:Hydrazones; D011724:Pyridazines; D000077464:Simendan